-
261
Reaction-Diffusion on a Spatial Mathematical Model of Cancer Immunotherapy with Effector Cells and IL-2 Compounds’ Interactions
Published 2021-01-01“…Immunotherapy is one of the future treatments applicable in most cases of cancer including malignant cancer. …”
Get full text
Article -
262
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
Published 2025-02-01Subjects: Get full text
Article -
263
Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
264
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
Published 2025-01-01“…Abstract The efficacy of cancer immunotherapy relies on a sufficient amount of functional immune cells. …”
Get full text
Article -
265
Efficacy and safety of immunotherapy in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma: a multicenter retrospective study
Published 2025-01-01“…The efficacy and safety of immunotherapy in pLELC, especially in second-line settings, remain inadequately explored. …”
Get full text
Article -
266
Advancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization
Published 2025-01-01“…In immunogenomics, AI can process vast amounts of genomic and multi-omic data to identify biomarkers associated with immunotherapy responses and disease prognosis, thus providing strong support for personalized treatments. …”
Get full text
Article -
267
Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
Published 2022-01-01“…This study provides a theoretical foundation for developing immunotherapy drugs for HNSC patients. By evaluating larger cohorts, we can gain a deeper understanding of immunotherapy and provide direction for current research on immunotherapy strategies in HNSCs.…”
Get full text
Article -
268
BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice
Published 2025-02-01Subjects: Get full text
Article -
269
Efficacy and safety of sublingual immunotherapy using a combination of Dermatophagoides pteronyssinus and Blomia tropicalis extracts in patients with allergic rhinitis: A randomized, double-blind, placebo-controlled trial
Published 2025-02-01Subjects: “…Allergen immunotherapy…”
Get full text
Article -
270
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
Published 2025-02-01Subjects: Get full text
Article -
271
Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
Published 2025-01-01Subjects: Get full text
Article -
272
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
273
Immune Checkpoint Blockade in Melanoma – Earlier is Better?
Published 2024-09-01Subjects: Get full text
Article -
274
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection
Published 2024-11-01Subjects: Get full text
Article -
275
-
276
-
277
-
278
Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer
Published 2025-12-01Subjects: Get full text
Article -
279
Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy
Published 2025-01-01Subjects: Get full text
Article -
280
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article